Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1995-05-26
1999-03-09
Minnifield, Nita
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
424 9461, 4241841, 514 2, 514 12, 514 14, A61K 3900, A61K 3938, A61K 3800, A61K 3816
Patent
active
058796800
ABSTRACT:
The invention is directed to a pharmaceutical composition comprising a therapeutic amount of a glycosylated recombinantly-produced human glucocerebrosidase protein in a pharmaceutically acceptable carrier. The invention is further directed to a method of treating Gaucher's disease comprising administering to a subject afflicted with Gaucher's disease a therapeutic amount of a pharmaceutical composition comprising a therapeutic amount of a glycosylated recombinantly-produced human glucocerebrosidase protein in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 3910822 (1975-10-01), Pentchev et al.
patent: 4386026 (1983-05-01), Ponpipom et al.
patent: 4745051 (1988-05-01), Smith et al.
patent: 5236838 (1993-08-01), Rasmussen et al.
Choudary et al., "The Molecular Biology of Gaucher Disease and the Potential for Gene Therapy", Cold Spring Harbor Lab. (1986).
Dinur et al., Proc. Natl. Acad. Sci. USA 83: 1660-1664 (1986).
Sorge et al., Proc. Natl. Acad. Sci. USA 82: 7289-7293 (1985).
Tsuji et al., The Journal of Biological Chemistry 261: 50-53 (1986).
Takasaki et al., The Journal of Biological Chemistry 259: 10112-10117 (1984).
Furbish et al., Proc. Natl. Acad. Sci. USA 74: 3560-3563 (1977).
Basu et al., The Journal of Biological Chemistry 259: 1714-1719 (1984).
Erickson et al., The Journal of Biological Chemistry 260: 14319-14324 (1985).
Choudary et al., Mol. Biol. Med. 3: 293-299 (1986).
Sorge et al., Proc. Natl. Acad. Sci. USA 84: 906-909 (1987).
Sorge et al., Proc. Natl. Acad. Sci. USA 82: 5442-5445 (1985).
Beutler et al., Proc. Natl. Acad. Sci. USA 83: 7472-7474 (1986).
Grabowski et al., Am. J. Hum. Genetics pp. 499-510 (1985).
Ginns et al., Biochem. Biophys. Res. Com. 123: 574-580 (1984).
Reiner et al., DNA 6: 101-108 (1987).
Brady et al., Birth Defects: Original Article Series 16: 361-368 (1980).
Prabhakara et al., "Retrovirus-mediated Transfer of the Human Glucocerebrosidase Gene to Gaucher Fibroblasts", Mol. Biol. Med. 3: 293-299 (1986).
Grabowski et al., "Acid-glucosidase: Enzymology and Molecular Biology of Gaucher Disease", Biochemistry and Molecular Biology.
Tsuji et al., "A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's Disease", New England Journal of Medicine 316: 570-575 (1987).
Tsuji et al., "Genetic Heterogeneity in Type 1 Gaucher Disease: Multiple Genetypes in Ashkenazic and Non-ashkenazic Individuals", Proc. Natl. Acad. Sci. USA 85: 2349-2352 (1988).
Smith et al., Mol. and Cell. Biol. 3(12): 2156-2165 (1983).
Luckow et al., Bio/Technology 6: 47-55 (1988).
Cameron et al., TIBTECH 7: 66-70 (1989).
Lebacq-Verheyden et al., Mol. and Cell. Biol. 8: 3129-3135 (1988).
Choudary et al. 1986 DNA 5,1:78.
Choudary et al. 1986a DNA 5,1:78.
Daebber et al. 1982. JBC. 257(5):2193-99.
Brady, 1983. In:Structural Carbohydrates in the Liver ed. Popper et al. pp. 497-505.
Takasaki et al. JBC 1984 259(16):10112-117.
Eliason William K.
Ginns Edward J.
LaMarca Mary E.
Martin Brian
Maysak Kara A.
Minnifield Nita
The United States of America as represented by the Department of
LandOfFree
Cloned DNA for synthesizing unique glucocerebrosidase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cloned DNA for synthesizing unique glucocerebrosidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloned DNA for synthesizing unique glucocerebrosidase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1317918